Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
When drug development gets personal
A brain cancer diagnosis changed how one biotech investor thinks about the patient experience. He shares his story on "The Top Line."
Ayla Ellison
,
Will Maddox
Oct 30, 2026 9:28am
How we picked the Fierce 15
Oct 9, 2026 7:21am
Inside the growing world of biopharma prediction markets
Sep 18, 2026 9:39am
The future of RAS inhibitors
Sep 11, 2026 9:48am
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Aug 7, 2026 8:42am
5 emerging biotech hubs
Jul 17, 2026 9:18am